FreeCME

Recent Developments in Immuno-oncology: Biomarkers, Pan-tumor Studies, Novel Treatment Combinations, and the Management of Adverse Events Track 2: Biomarkers for Immunotherapies Across Tumor Type

CME: 1.0

Post a comment to this article